California Public Employees Retirement System’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-73,925
Closed -$1.8M – 1552
2021
Q1
$1.8M Sell
73,925
-15,805
-18% -$458K ﹤0.01% 2073
2020
Q4
$2.87M Buy
89,730
+61,700
+220% +$2.02M ﹤0.01% 1771
2020
Q3
$925K Buy
+28,030
New +$1.21M ﹤0.01% 2336

Other funds holding ADCT

California Public Employees Retirement System's ADCT Position: Q2 2021 in Review

California Public Employees Retirement System sold out of ADC Therapeutics (ADCT) in Q2 2021, closing a stake of 73,925 shares — an estimated $1.8M sold.

California Public Employees Retirement System first reported a position in ADCT in Q3 2020 and held it in 3 quarters. The position peaked at $2.87M in Q4 2020. 56 funds tracked by Wall St. Rank hold ADCT as of Q2 2021.

  • California Public Employees Retirement System reported no remaining ADC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 73,925 ADC Therapeutics shares in Q2 2021, an estimated $1.8M.
  • California Public Employees Retirement System first reported a position in ADC Therapeutics in Q3 2020 and held it in 3 quarters.
  • California Public Employees Retirement System's ADC Therapeutics position peaked at $2.87M in Q4 2020.
  • 56 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.